Literature DB >> 24293180

Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.

Caroline T Nguyen1, Michael I MacEntee, Barbara Mintzes, Thomas L Perry.   

Abstract

BACKGROUND: Over three-quarters of the older population take medications that can potentially cause dry mouth. Physicians or pharmacists rarely inform patients about this adverse effect and its potentially severe damage to the teeth, mouth and general health.
OBJECTIVES: The objectives of this study were to (1) identify warnings in the literature about dry mouth associated with the most frequently prescribed pharmaceutical products in Canada; and (2) consider how this information might be obtained by physicians, pharmacists and patients.
METHODS: Monographs on the 72 most frequently prescribed medications during 2010 were retrieved from the Compendium of Pharmaceuticals and Specialties (CPS, a standard drug information reference for physicians and pharmacists), the National Library of Medicine's 'DailyMed' database, directly from the manufacturers, and from a systematic search of biomedical journals.
RESULTS: The CPS provided monographs for 43% of the medications, and requests to manufacturers produced the remaining monographs. Mentions of dry mouth were identified in 61% of the products (43% amongst CPS monographs; an additional 43% amongst manufacturers' monographs; 7% in the DailyMed database and 7% from biomedical journals); five medications had contradictory reports in different monographs.
CONCLUSION: Nearly two-thirds (61%) of the most commonly prescribed medications can cause dry mouth, yet warnings about this adverse effect and its potentially serious consequences are not readily available to physicians, pharmacists, dentists or patients.

Entities:  

Mesh:

Year:  2014        PMID: 24293180     DOI: 10.1007/s40266-013-0141-5

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  138 in total

1.  Oral status, oral hygiene habits and caries risk factors in home-dwelling elderly dependent on moderate or substantial supportive care for daily living.

Authors:  Ella Strömberg; Marie-Louise Hagman-Gustafsson; Anette Holmén; Inger Wårdh; Pia Gabre
Journal:  Community Dent Oral Epidemiol       Date:  2011-11-09       Impact factor: 3.383

2.  A double blind comparison of the efficacy and safety of trazodone and imipramine in endogenous depression.

Authors:  M M Al-Yassiri; S I Ankier; P K Bridges
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

3.  A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.

Authors:  Antonio E Nardi; Rafael C Freire; Marina D Mochcovitch; Roman Amrein; Michelle N Levitan; Anna L King; Alexandre M Valença; André B Veras; Flávia Paes; Aline Sardinha; Isabella Nascimento; Valfrido L de-Melo-Neto; Gisele P Dias; Adriana Cardoso de O E Silva; Gastão L Soares-Filho; Rafael T da Costa; Marco A Mezzasalma; Marcele R de Carvalho; Ana C de Cerqueira; Jaime E Hallak; José A Crippa; Marcio Versiani
Journal:  J Clin Psychopharmacol       Date:  2012-02       Impact factor: 3.153

4.  Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.

Authors:  G Pezzella; R Moslinger-Gehmayr; A Contu
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

Review 5.  Dry mouth and its effects on the oral health of elderly people.

Authors:  Michael D Turner; Jonathan A Ship
Journal:  J Am Dent Assoc       Date:  2007-09       Impact factor: 3.634

Review 6.  Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

Authors:  ZhiLong Dong; ZhiPing Wang; KeHu Yang; YaLi Liu; WenHui Gao; WenYuan Chen
Journal:  Syst Biol Reprod Med       Date:  2009-08       Impact factor: 3.061

7.  Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.

Authors:  Kazuo Mihara; Norio Yasui-Furukori; Tsuyoshi Kondo; Masayuki Ishida; Shingo Ono; Tadashi Ohkubo; Takako Osanai; Kazunobu Sugawara; Koichi Otani; Sunao Kaneko
Journal:  Ther Drug Monit       Date:  2002-08       Impact factor: 3.681

8.  Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study.

Authors:  G Davidoff; M Guarracini; E Roth; J Sliwa; G Yarkony
Journal:  Pain       Date:  1987-05       Impact factor: 6.961

9.  Interventions to manage symptoms at the end of life.

Authors:  Charles F von Gunten
Journal:  J Palliat Med       Date:  2005       Impact factor: 2.947

10.  Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

Authors:  Martin Lambert; Rüdiger Holzbach; Steffen Moritz; Nils Postel; Michael Krausz; Dieter Naber
Journal:  Int Clin Psychopharmacol       Date:  2003-09       Impact factor: 1.659

View more
  1 in total

Review 1.  A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.

Authors:  Andy Wolff; Revan Kumar Joshi; Jörgen Ekström; Doron Aframian; Anne Marie Lynge Pedersen; Gordon Proctor; Nagamani Narayana; Alessandro Villa; Ying Wai Sia; Ardita Aliko; Richard McGowan; Alexander Ross Kerr; Siri Beier Jensen; Arjan Vissink; Colin Dawes
Journal:  Drugs R D       Date:  2017-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.